$4.00
0.071.78%
Últ. Act.: Nov 20, 3:12 PM

The average analyst price target for Atea Pharmaceuticals is $9, 125.0% above the current price. The one analyst covering it rates it Outperform. Targets range from $8 to $10. The latest change came on Nov 16, 2026, when Morgan Stanley raised its price target on Atea Pharmaceuticals from $7 to $8 and kept an Equal-Weight rating.
Price Target Range — 5 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months